Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a menopause-mimicking drug fight fatty liver in endometriosis patients?

NCT ID NCT06523530

First seen Feb 03, 2026 · Last updated Jun 22, 2026 · Updated 28 times

Summary

This study tests whether goserelin acetate, a drug that temporarily stops menstruation (like a short-term menopause), can reduce liver fat in women with endometriosis who also have fatty liver disease. Researchers will measure liver fat and stiffness using ultrasound in 62 women over 6 months. The goal is to see if this approach can improve liver health.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • 1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki

    RECRUITING

    Thessaloniki, 56403, Greece

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • 424 General Military Hospital

    RECRUITING

    Thessaloniki, 56429, Greece

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Goserelin acetate (Zoladex), a drug that temporarily stops menstruation

What this could lead to

If it works, this could point toward a new way to treat fatty liver disease in women with endometriosis by using a temporary menopause-like state.

What could go wrong

This is a small, early-phase trial with only 62 participants. The drug causes temporary menopause, which may have side effects like hot flashes and bone thinning, and the liver benefit is not yet proven.

Conditions

The condition(s) this trial relates to.

cirrhosis of liver endometriosis metabolic dysfunction-associated steatotic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.